Human Urinary Kallidinogenase
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Human Urinary Kallidinogenase, covering 2014-10-08 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Human Urinary Kallidinogenase Combined With Reteplase Intravenous Thrombolysis in the Treatment of Acute Ischemic Stroke [NA]